Showing results (671-680 of 691) with videos related to
Sort By:
Pageof 70
Biorxiv : the Preprint Server for Biology|February 20, 2025
Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanomaTyler J Aprati, Chi-Ping Day, Daniel Lee, et al.Biorxiv : the Preprint Server for Biology|June 19, 2023
Multi-scale models reveal hypertrophic cardiomyopathy MYH7 G256E mutation drives hypercontractility and elevated mitochondrial respirationSoah Lee, Alison S Vander Roest, Cheavar A Blair, et al.Cell Reports|April 14, 2021
Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtypeFátima Valdés-Mora, Robert Salomon, Brian Stewart Gloss, et al.The Lancet. Neurology|December 15, 2023
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trialAndrew McGarry, Shane Rosanbalm, Mika Leinonen, et al.Nature Materials|October 30, 2024
Trace benzene capture by decoration of structural defects in metal-organic framework materialsYu Han, Wenyuan Huang, Meng He, et al.Organic Letters|July 24, 2023
Design and Discovery of Water-Soluble Benzooxaphosphole-Based Ligands for Hindered Suzuki-Miyaura Coupling Reactions with Low Catalyst LoadArun D R Shada, Hari P R Mangunuru, Leila Terrab, et al.BMJ Leader|April 25, 2025
Huddles for unprofessional behaviours in the healthcare setting that may require immediate investigation, inquiry or interventionCynthia A Baldwin, Thomas F Catron, Gerald B Hickson, et al.Proceedings of the National Academy of Sciences of the United States of America|April 29, 2024
Incomplete-penetrant hypertrophic cardiomyopathy MYH7 G256E mutation causes hypercontractility and elevated mitochondrial respirationSoah Lee, Alison S Vander Roest, Cheavar A Blair, et al.International Forum of Allergy & Rhinology|July 7, 2026
Systemic Corticosteroids in the Management of Sinonasal Disease: An Evidence-Based Expert ReviewAndrew Thamboo, Deanna Gigliotti, Eugenio De Corso, et al.Lung Cancer (Amsterdam, Netherlands)|October 24, 2025
Real-world outcomes of second-line carboplatin plus pemetrexed after first-line osimertinib in EGFR-mutant advanced NSCLC: An international multicentre cohort studyIgor Gomez-Randulfe, Federico Monaca, Ornella Cantale, et al.Pageof 70